Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses.
暂无分享,去创建一个
Ruili Huang | Menghang Xia | David M. Reif | Daniel M. Rotroff | Nisha S. Sipes | R. Judson | D. Dix | T. Knudsen | Ruili Huang | K. Houck | Matt T. Martin | M. Xia | D. Reif | D. Rotroff | D. Filer | N. Sipes | Thomas B. Knudsen | Keith A. Houck | Nisha S. Sipes | Richard S. Judson | David M. Reif | David J. Dix | Daniel M. Rotroff | Matt T. Martin | Dayne L. Filer
[1] Ruili Huang,et al. Using in Vitro High Throughput Screening Assays to Identify Potential Endocrine-Disrupting Chemicals , 2012, Environmental health perspectives.
[2] M. Marino,et al. Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: Studies on the possible mechanism of action in DU145 cells , 2007, Molecular and Cellular Endocrinology.
[3] Rosalind,et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.
[4] John P Sumpter,et al. Predicted‐no‐effect concentrations for the steroid estrogens estrone, 17β‐estradiol, estriol, and 17α‐ethinylestradiol , 2012, Environmental toxicology and chemistry.
[5] G. Larsen,et al. Atrazine is a competitive inhibitor of phosphodiesterase but does not affect the estrogen receptor. , 2004, Toxicology letters.
[6] R. Zoeller,et al. Evaluating the effects of endocrine disruptors on endocrine function during development. , 1999, Environmental health perspectives.
[7] Sheng-Xiang Lin,et al. The Contribution of 17beta-Hydroxysteroid Dehydrogenase Type 1 to the Estradiol-Estrone Ratio in Estrogen-Sensitive Breast Cancer Cells , 2012, PloS one.
[8] E. Nelson,et al. The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis. , 2013, Bone.
[9] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[10] Vasantha Padmanabhan,et al. Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus. , 2010, Toxicology and applied pharmacology.
[11] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[12] J. Gustafsson,et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.
[13] Linda S Birnbaum,et al. Cancer and developmental exposure to endocrine disruptors. , 2002, Environmental health perspectives.
[14] A. Kolasa,et al. Localisation of oestrogen receptors (ERalpha and ERbeta) in the human and rat epididymides. , 2003, Folia morphologica.
[15] Robert J Kavlock,et al. Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells. , 2013, Chemical research in toxicology.
[16] R J Kavlock,et al. Endocrine disruptors and reproductive development: a weight-of-evidence overview. , 1997, The Journal of endocrinology.
[17] T H Shepard,et al. National toxicology program. , 1981, Teratology.
[18] G. Rimbach,et al. Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. , 2005, The Journal of nutrition.
[19] C. Sonnenschein,et al. Environmental causes of cancer: endocrine disruptors as carcinogens , 2010, Nature Reviews Endocrinology.
[20] J Ashby,et al. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. , 1997, Regulatory toxicology and pharmacology : RTP.
[21] E. Jensen,et al. Estrogen receptor (ER) , a modulator of ER in the uterus , 2000 .
[22] Carolyn L. Smith,et al. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. , 2000, The Journal of pharmacology and experimental therapeutics.
[23] K. Korach,et al. Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.
[24] J. Westendorf,et al. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. , 2001, Toxicology.
[25] J. Gustafsson,et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.
[26] J. Gustafsson,et al. Estrogen receptor beta--a new dimension in estrogen mechanism of action. , 1999, The Journal of endocrinology.
[27] Rena Li,et al. Estrogen synthesis and signaling pathways during aging: from periphery to brain. , 2013, Trends in molecular medicine.
[28] R. Sharpe,et al. ERβ1 and the ERβ2 Splice Variant (ERβcx/β2) Are Expressed in Distinct Cell Populations in the Adult Human Testis , 2002 .